Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Human immunodeficiency virus 1 | Aberrant vpr protein | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.357 | 1 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.024 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.357 | 0.357 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.7676 | 0.7676 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0019 | 0.0086 | 0.024 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0019 | 0.0086 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0066 | 0.2947 | 0.8257 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0086 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.357 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 1 | 1 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0069 | 0.3088 | 0.8652 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.357 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.024 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0066 | 0.2947 | 0.8257 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0066 | 0.2947 | 0.8257 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.357 | 1 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0069 | 0.3088 | 0.8652 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.024 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0019 | 0.0086 | 1 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0069 | 0.3088 | 0.8652 |
Brugia malayi | jmjC domain containing protein | 0.0066 | 0.2947 | 0.2947 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.357 | 0.357 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.357 | 0.357 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0019 | 0.0086 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0019 | 0.0086 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.357 | 1 |
Brugia malayi | jmjC domain containing protein | 0.0066 | 0.2947 | 0.2947 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0019 | 0.0086 | 1 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0066 | 0.2947 | 0.8257 |
Brugia malayi | isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.0086 |
Schistosoma mansoni | jumonji domain containing protein | 0.0066 | 0.2947 | 0.8257 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.3088 | 0.3088 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.344 | 0.344 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.357 | 0.357 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.002 | 0.0125 | 0.0125 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.7676 | 0.7676 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0019 | 0.0086 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0066 | 0.2947 | 0.8257 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.357 | 1 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0066 | 0.2947 | 0.2947 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.024 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0086 | 1 |
Brugia malayi | SWIRM domain containing protein | 0.0074 | 0.344 | 0.344 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0019 | 0.0086 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0125 | 0.0125 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.357 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.7676 | 0.7676 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.024 |
Onchocerca volvulus | 0.0182 | 1 | 1 | |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.0086 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.357 | 0.357 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0066 | 0.2947 | 0.8257 |
Brugia malayi | RNA binding protein | 0.0076 | 0.357 | 0.357 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.024 |
Brugia malayi | Isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.0086 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.3088 | 0.3088 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0086 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.5131 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.